Association of γA/γ′ fibrinogen levels and coronary artery disease

Thrombosis and Haemostasis

Volumn 88, Issue 1, 2002, Pages 26-31

  Lovely, Rehana S ^a   Falls, Lisa A ^a   Al Mondhiry, Hamid A ^a   Chambers, Charles E ^a   Sexton, Gary J ^a   Ni, Hanyu ^a   Farrell, David H ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Age; Coronary; Epidemiology; Fibrinogen; Gender

Indexed keywords

BLOOD CLOTTING FACTOR 8; ENZYME PRECURSOR; FIBRINOGEN; ISOPROTEIN; THROMBIN; FIBRINOPEPTIDES GAMMA; MESSENGER RNA;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BINDING SITE; BLOOD DONOR; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; EXON; FEMALE; FIBRIN CLOT; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HUMAN; INTRON; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; VASCULAR RESISTANCE; ALTERNATIVE RNA SPLICING; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY ATHEROSCLEROSIS; GENETICS; MIDDLE AGED; REGRESSION ANALYSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RNA, MESSENGER; SEX FACTORS;

EID: 0036301930     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613148     Document Type: Article

References (39)

1. Human plasma fibrinogen heterogeneity: Evidence for an extended carboxyl-terminal sequence in a normal γ chain variant (γ′)
2. Demonstration of a large molecular weight variant of the γ chain of normal human plasma fibrinogen
3. Structural and chromatographic heterogeneity of normal plasma fibrinogen associated with the presence of three γ-chain types with distinct molecular weights
4. Carboxy-terminal amino acid sequence of a human fibrinogen γ-chain variant (γ′)
5. Human fibrinogen heterogeneities: Identification of γ chain variants
6. γ and γ′ chains of human fibrinogen are produced by alternative mRNA processing
7. Structure of the human γ-fibrinogen gene: Alternate mRNA splicing near the 3′ end of the gene produces γA and γB forms of γ-fibrinogen
8. Role of fibrinogen α and γ chain sites in platelet aggregation
9. Purification and functional characterization of homodimeric γB-γB fibrinogen from rat plasma
10. Binding of recombinant fibrinogen mutants to platelets
11. Organization of the rat γ-fibrinogen gene: Alternative mRNA splice patterns produce the γA and γB (γ′) chains of fibrinogen
12. Tissue-specific and ubiquitous expression of fibrinogen γ chain mRNA
13. Recombinant human fibrinogen and sulfation of the γ′ chain
14. Plasma factor XIII binds specifically to fibrinogen molecules containing γ′ chains
15. Interactions of human fibrinogens with factor XIII: Roles of calcium and the γ′ peptide
16. Identification and characterization of thrombin binding sites on fibrin
17. The amino acid sequence in fibrin responsible for high affinity thrombin binding
18. Resistance of γA/γ′ fibrin clots to fibrinolysis
19. Sol Sherry lecture on thrombosis: Research on clot stabilization provides clues for improving thrombolytic therapies
20. Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: Implications for heparin efficacy
21. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors
22. Plasma γA/γ′ fibrinogen ratio, a marker of arterial thrombotic activity: A new potential cardiovascular risk factor?
23. Fibrinogen as a risk factor for stroke and myocardial infarction
24. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
25. Fibrinogen and risk of cardiovascular disease: The Framingham Study
26. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies
27. Fibrinogen and factor VII in the prediction of coronary risk: Results from the PROCAM study in healthy men
28. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study
29. Fibrinogen synthesis in serum-free hepatocyte cultures: Stimulation by glucocorticoids
30. Variation in the promoter region of the beta fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers
31. Fibrinogen genotype and risk of peripheral atherosclerosis
32. Fibrinogen polymorphisms and atherothrombotic disease
33. Determinants of population changes in fibrinogen and factor VII over 6 years: The Atherosclerosis in Communities (ARIC) study
34. Long-term influence of fibrinogen on initial and recurrent cardiovascular events in men and women
35. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study
36. Placental anti-coagulant protein-I: Measurement in extracellular fluids and cells of the hemostatic system
37. Fibrinogen and its degradation products as thrombotic risk factors
38. Fibrinogen precursors: Order of assembly of fibrinogen chains
39. The role of γA/γ′ fibrinogen in plasma factor XIII activation